Arterial ketone body ratio in clinical liver transplantation.
Kitabayashi
K
K
Section of Transplantation Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Gores
G J
GJ
Krom
R A
RA
D020155:3-Hydroxybutyric Acid / Q000097:blood; D000090:Acetoacetates / Q000097:blood; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000097:blood / Q000188:drug therapy; D006085:Graft Survival / Q000502:physiology*; D006498:Hepatectomy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007657:Ketone Bodies / Q000097:blood*; D016031:Liver Transplantation / Q000276:immunology / Q000379:methods / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012044:Regression Analysis; D013997:Time Factors; D017211:Treatment Failure
D000090:Acetoacetates; D007166:Immunosuppressive Agents; D007657:Ketone Bodies; C016635:acetoacetic acid; D000410:Alanine Transaminase; D001663:Bilirubin; D020155:3-Hydroxybutyric Acid